These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1282231)

  • 1. Intravitreal neovascular tissue of proliferative diabetic retinopathy: an immunohistochemical study.
    Hosoda Y; Okada M; Matsumura M; Ogino N; Honda Y; Nagai Y
    Ophthalmic Res; 1992; 24(5):260-4. PubMed ID: 1282231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study.
    Hosoda Y; Okada M; Matsumura M; Ogino N; Honda Y; Nagai Y
    Ophthalmic Res; 1993; 25(5):289-94. PubMed ID: 8259261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic preretinal membranes. An immunohistochemical study.
    Jerdan JA; Michels RG; Glaser BM
    Arch Ophthalmol; 1986 Feb; 104(2):286-90. PubMed ID: 3947305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology of intraocular neovascularization].
    Hori S
    Nippon Ganka Gakkai Zasshi; 1990 Dec; 94(12):1103-21. PubMed ID: 1707214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological and immunohistochemical study of idiopathic epiretinal membrane.
    Okada M; Ogino N; Matsumura M; Honda Y; Nagai Y
    Ophthalmic Res; 1995; 27(2):118-28. PubMed ID: 8538984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
    Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitreous oxygen tension of proliferative diabetic retinopathy].
    Maeda N; Tano Y; Ikeda T; Imai T; Hamano H; Manabe R
    Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):511-5. PubMed ID: 1621593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
    Snead DR; James S; Snead MP
    Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical study of idiopathic and secondary epiretinal membrane].
    Kinouchi R; Hirokawa H; Miyokawa N; Nomiyama T; Hikichi T; Yoshida A
    Nippon Ganka Gakkai Zasshi; 2001 Oct; 105(10):673-81. PubMed ID: 11692613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localisation of opticin in human proliferative retinal disease.
    Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P
    Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
    Barber AJ; Antonetti DA; Gardner TW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Posterior hyaloid membrane as structural base of growth of neovascular tissue in proliferative diabetic retinopathy].
    Krasnov MM; Sdobnikova SV; Fedorov AA; Stoliarenko GE
    Vestn Oftalmol; 1998; 114(3):16-20. PubMed ID: 9720391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of glial involvement in proliferative diabetic retinopathy.
    Ohira A; de Juan E
    Ophthalmologica; 1990; 201(4):187-95. PubMed ID: 2077455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperconvolution of the inner limiting membrane in vitreomaculopathies.
    Snead DR; Cullen N; James S; Poulson AV; Morris AH; Lukaris A; Scott JD; Richards AJ; Snead MP
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):853-62. PubMed ID: 15480733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The current data on the proliferative process in diabetic retinopathy].
    Mazurina NK
    Vestn Oftalmol; 1999; 115(3):37-40. PubMed ID: 10432854
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
    Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
    Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.